Trial Profile
Effect of everolimus-eluting bioresorbable scaffold in patients with long lesions (>32mm)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angina pectoris; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- 28 May 2015 New trial record